BlockmiR AONs as Site-Specific Therapeutic MBNL Modulation in Myotonic Dystrophy 2D and 3D Muscle Cells and HSA(LR) Mice

The symptoms of Myotonic Dystrophy Type 1 (DM1) are multi-systemic and life-threatening. The neuromuscular disorder is rooted in a non-coding CTG microsatellite expansion in the DM1 protein kinase (DMPK) gene that, upon transcription, physically sequesters the Muscleblind-like (MBNL) family of splic...

Descripción completa

Detalles Bibliográficos
Autores principales: Overby, Sarah J., Cerro-Herreros, Estefanía, Espinosa-Espinosa, Jorge, González-Martínez, Irene, Moreno, Nerea, Fernández-Costa, Juan M., Balaguer-Trias, Jordina, Ramón-Azcón, Javier, Pérez-Alonso, Manuel, Møller, Thorleif, Llamusí, Beatriz, Artero, Rubén
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10141141/
https://www.ncbi.nlm.nih.gov/pubmed/37111604
http://dx.doi.org/10.3390/pharmaceutics15041118

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10141141/
https://www.ncbi.nlm.nih.gov/pubmed/37111604
http://dx.doi.org/10.3390/pharmaceutics15041118

Ejemplares similares